New York, NY -- (SBWIRE) -- 12/09/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Cross Country Healthcare, Inc (NASDAQ:CCRN), Golar LNG Partners LP (NASDAQ:GMLP), LIGHTSTREAM RES (OTCMKTS:LSTMF), Boston Scientific Corporation (NYSE:BSX)
Cross Country Healthcare, Inc (NASDAQ:CCRN) showed a volume of 1.98 million shares by the end of last trade whereas the average volume of the stock remained 265,700.00 shares. The stock opened the session at $7.12 but then moved to $6.94. At that price, the stock showed a negative performance of -1.42%. Cross Country Healthcare, Inc. (Cross Country) is engaged in the healthcare staffing services business offering a suite staffing and outsourcing services to the healthcare market. The Company segments include nurse and allied staffing, physician staffing, and other human capital management services. The nurse and allied staffing business segment provides travel nurse and allied staffing services and per diem nurse services primarily to acute care hospitals.
Will LPR Get Buyers Even After The Recent Rally? Find Out Here
Golar LNG Partners LP (NASDAQ:GMLP) opened the session at $29.04 and closed the session at $29.02. The stock showed a negative performance of -6.21% in previous trading session. Traded with volume of 3.02 million shares in the prior session and the average volume of the stock remained 157,990.00 shares. Golar LNG Partners LP (the Partnership) is a limited partnership formed as a wholly owned subsidiary of Golar LNG Limited (Golar), an independent owner and operator of floating storage re-gasification units (FSRUs) and liquefied natural gas (LNG) carriers, to own and operate FSRUs and LNG carriers under long-term charters. The vessels in its fleet are chartered to BG Group, Pertamina, Petrobras and Dubai Supply Authority.
Has GMLP Found The Bottom And Ready To Gain Momentum? Find Out Here
LIGHTSTREAM RES (OTCMKTS:LSTMF) opened the session at $5.36 and closed the session at $5.23. The stock showed a negative performance of -0.76% in previous trading session. Traded with volume of 372,047.00 shares in the prior session and the average volume of the stock remained 214,172.00 shares. The beta of the stock remained 3.12.
Why Should Investors Buy LSTMF After the Recent Fall? Just Go Here and Find Out
Boston Scientific Corporation (NYSE:BSX) the stock advanced 4.50% and finished the session at $11.85. Traded with volume of 11.57 million shares in the prior session and the average volume of the stock remained 11.39 million shares. The beta of the stock remained 1.07. Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions, Urology/Women’s Health, Neuromodulation, and Electrophysiology. In January 2011, it completed the acquisition of Intelect Medical, Inc. In June 2012, the Company acquired Cameron Health, Inc. of San Clemente,
Will BSX Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)